Effect of Blueberry Consumption on Metabolic Syndrome & DNA Damage
Highbush Blueberries, the DNA-damage of Obesity, Somatic Mutations and Metabolic Syndrome
Sponsor: U.S. Highbush Blueberry Council
This NA trial investigates DNA Damage and Insulin Resistance and is currently completed. U.S. Highbush Blueberry Council leads this study, which shows 8 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Sep 2020 — Jan 2021 [monthly]
Unknown Status NA
-
Aug 2019 — Sep 2020 [monthly]
Unknown Status NA
▶ Show 3 earlier versions
-
Mar 2019 — Aug 2019 [monthly]
Unknown Status NA
Status: Enrolling By Invitation → Unknown Status
-
Jun 2018 — Mar 2019 [monthly]
Enrolling By Invitation NA
-
Jan 2017 — Jun 2018 [monthly]
Enrolling By Invitation NA
First recorded
Jan 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- U.S. Highbush Blueberry Council
- UCSF Benioff Children's Hospital Oakland
- USDA Agricultural Research Station in Albany, CA
For direct contact, visit the study record on ClinicalTrials.gov .